Loading...
•
Mar 31, 2024
Strata Critical Medical Q1 2024 Earnings Report
Blade Air Mobility reported financial results, achieving record-high medical revenue and improved net loss and Adjusted EBITDA compared to the prior year.
Key Takeaways
Blade Air Mobility reported a 13.8% increase in total revenue to $51.5 million, driven by a 34.6% increase in Medical revenue. The company's net loss improved by 58.5% to $(4.2) million, and Adjusted EBITDA improved by 54.1% to $(3.5) million.
Achieved record-high Medical revenue of $36.0 million, a 34.6% increase versus the prior year period.
Net loss improved by $6.0 million versus the prior year to $(4.2) million.
Adjusted EBITDA improved by $4.2 million versus the prior year to $(3.5) million.
Confirmed guidance for Adjusted EBITDA profitability in full-year 2024 and Adjusted EBITDA in the double-digit millions for 2025.
Forward Guidance
The Company is reaffirming its guidance from March, for the full year 2024, we expect Revenue of $240 million to $250 million and Positive Adjusted EBITDA. For the full year 2025, we expect Double-digit year-over-year revenue growth and Double-digit Adjusted EBITDA
Positive Outlook
- Revenue of $240 million to $250 million is expected for full year 2024
- Positive Adjusted EBITDA is expected for full year 2024
- Double-digit year-over-year revenue growth is expected for full year 2025
- Double-digit Adjusted EBITDA is expected for full year 2025
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...